TEM8/ANTXR1 Antibody [PE/Cy7]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77233PECY7
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Flow Cytometry
Label
PE/Cy7 (Excitation = 488 nm, Emission = 778 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
1 mg/ml
Product Specifications
Immunogen
Antibody was raised against a peptide corresponding to 13 amino acids near the center of human ATR. The immunogen is located within amino acids 220 - 270 of ATR. Amino Acid Squence: RGNGFRHARNVDR
Specificity
Recognizes all three isoforms of ATR.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Theoretical MW
45 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Applications for TEM8/ANTXR1 Antibody [PE/Cy7]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Ion exchange chromatography
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: TEM8/ANTXR1
Long Name
Tumor Endothelial Marker 8/Anthrax Toxin Receptor 1
Alternate Names
ANTXR1
Gene Symbol
ANTXR1
Additional TEM8/ANTXR1 Products
Product Documents for TEM8/ANTXR1 Antibody [PE/Cy7]
Product Specific Notices for TEM8/ANTXR1 Antibody [PE/Cy7]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...